New pill could help ITP patients who failed other treatments
NCT ID NCT06721013
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a drug called pirtobrutinib in adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risks. The trial has two parts: first, finding safe doses, then comparing pirtobrutinib to a placebo to see if it raises platelet counts. About 68 people who have not responded to prior treatments will take the pill daily for up to 28 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
pirtobrutinib
What this could lead to
If it works, this could offer a new oral treatment option for adults with ITP who have not responded to other therapies.
What could go wrong
This is an early phase 1/2 trial with only 68 participants, so results may not apply to everyone. Side effects and lack of efficacy are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE THROMBOCYTOPENIA (ITP) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aidport sp z o.o.
RECRUITINGSkorzewo, 60-185, Poland
-
Asan Medical Center
RECRUITINGSeoul, 05505, South Korea
-
Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi IRCCS
RECRUITINGBologna, 40138, Italy
-
Azienda Sanitaria Universitaria Giuliano Isontina (ASU GI)
NOT_YET_RECRUITINGTrieste, 34129, Italy
-
Bleeding and Clotting Disorders Institute
NOT_YET_RECRUITINGPeoria, Illinois, 61614, United States
-
Bristol Haematology and Oncology Centre
RECRUITINGBristol, BS2 8ED, United Kingdom
-
CHU Bordeaux - Hôpital Haut-Lévêque
RECRUITINGPessac, 33604, France
-
CHU Dijon - Hopital du Bocage
RECRUITINGDijon, 21034, France
-
Clinica Universidad de Navarra
RECRUITINGPamplona, 31008, Spain
-
Clinical Research Alliance
RECRUITINGWestbury, New York, 11590, United States
-
Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico
RECRUITINGMilan, 20122, Italy
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
RECRUITINGRoma, 00168, Italy
-
Hammersmith Hospital
NOT_YET_RECRUITINGLondon, W12 0HS, United Kingdom
-
Haukeland University Hospital
NOT_YET_RECRUITINGBergen, 5021, Norway
-
Hematology Hospital of the Chinese Academy of Medical Sciences
NOT_YET_RECRUITINGTianjin, 300020, China
-
Hospital Clinic de Barcelona
RECRUITINGBarcelona, 08036, Spain
-
Hospital General Universitario Morales Meseguer
RECRUITINGMurcia, 30008, Spain
-
Hospital Universitario de Burgos
RECRUITINGBurgos, 09006, Spain
-
Hôpital Henri Mondor
RECRUITINGCréteil, 94010, France
-
Leicester Royal Infirmary
RECRUITINGLeicester, LE1 5WW, United Kingdom
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
MICS Centrum Medyczne Torun
RECRUITINGTorun, 87-100, Poland
-
Mayo Clinic
NOT_YET_RECRUITINGRochester, Minnesota, 55905, United States
-
MedStar Georgetown University Hospital
RECRUITINGWashington D.C., District of Columbia, 20007, United States
-
Nanfang Hospital of Southern Medical University
NOT_YET_RECRUITINGGuangzhou, 510515, China
-
OUH
RECRUITINGOdense C, 5000, Denmark
-
Ochsner Clinic Foundation
RECRUITINGNew Orleans, Louisiana, 70121, United States
-
Pratia MCM Krakow
RECRUITINGKrakow, 30-727, Poland
-
Pratia Onkologia Katowice
RECRUITINGKatowice, 40-519, Poland
-
Pusan National University Hospital
RECRUITINGBusan, 49241, South Korea
-
Qilu Hospital of Shandong University
NOT_YET_RECRUITINGJinan, 250012, China
-
Royal London Hospital
NOT_YET_RECRUITINGLondon, E1 1FR, United Kingdom
-
Seoul National University Hospital
RECRUITINGSeoul, 03080, South Korea
-
Severance Hospital, Yonsei University Health System
RECRUITINGSeoul, 03722, South Korea
-
St James's University Hospital
RECRUITINGLeeds, LS9 7TF, United Kingdom
-
St. Olavs Hospital Hf, Universitetssykehuset i Trondheim
NOT_YET_RECRUITINGTrondheim, 7030, Norway
-
Stanford University
NOT_YET_RECRUITINGStanford, California, 94305-5406, United States
-
Sykehuset Ostfold, Kalnes
NOT_YET_RECRUITINGGrålum, 1714, Norway
-
Texas Oncology - Central South
NOT_YET_RECRUITINGAustin, Texas, 78758, United States
-
Texas Oncology Gulf Coast
NOT_YET_RECRUITINGThe Woodlands, Texas, 77380, United States
-
The Catholic University of Korea, Seoul St. Mary's Hospital
RECRUITINGSeoul, 06591, South Korea
-
USC Norris Comprehensive Cancer Center
RECRUITINGLos Angeles, California, 90033, United States
-
Union Hospital Tongji Medical College Huazhong University of Science and Technology
NOT_YET_RECRUITINGWuhan, 430022, China
-
University of Miami Hospital and Clinics Sylvester Comprehensive Cancer Center
NOT_YET_RECRUITINGMiami, Florida, 33136, United States
-
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu
NOT_YET_RECRUITINGWroclaw, 50-367, Poland